Intracranial atherosclerotic disease and resultant intracranial stenosis is a global leading
cause of stroke, and poses an ongoing treatment challenge. Among patients with …

Importance Previous randomized clinical trials did not demonstrate the superiority of
endovascular stenting over aggressive medical management for patients with symptomatic …

Background Intracranial atherosclerotic stenosis (ICAS) is associated with high risk of
recurrent strokes despite best medical management (MM). We aimed to synthesize the …

Background The superiority of balloon angioplasty plus aggressive medical management
(AMM) to AMM alone for symptomatic intracranial artery stenosis (sICAS) on efficacy and …

Background The optimal treatment for intracranial artery stenosis (ICAS) has not been
established. We retrospectively examined the initial and long-term outcomes associated with …

Objective To investigate the etiology of intracranial artery stenosis and the distribution
characteristics of intracranial artery atherosclerotic stenosis using high-resolution magnetic …

Intracranial atherosclerosis (ICAS) is one of the most common causes of stroke worldwide
and is associated with high risk of stroke recurrence. While the most common clinical …

Large artery intracranial atherosclerotic stenosis (ICAS) is one of the most common causes
of stroke worldwide and is associated with a particularly high risk of recurrent stroke …

Background The efficacy of percutaneous transluminal angioplasty and stenting (PTAS)
relative to medical management in treating symptomatic intracranial arterial stenosis (ICAS) …

Background Previous single-center studies have demonstrated that drug-coated balloons
(DCBs) may reduce restenosis rates, which is an important factor affecting the prognosis for …